Full Text
Preliminary Analysis of the Cost-Effectiveness of Pertuzmab in Patients with Her2-Positive Breast Cancer in Japan

Abstract

Authors

S Uechi K Moriwaki

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×